The concentrated buying by C-suite and a major holder at a single price suggests coordinated conviction ahead of a potential catalyst (e.g., clinical data, partnership). Monitor for upcoming press releases or SEC filings. The buying provides a floor near $18, but biotech risk remains high.
Price Chart
Executive Summary
Seven insiders at Braveheart Bio, including the CEO, CFO, CDO, and a 10% owner (Forbion), collectively purchased $34.83M in open-market shares at $18.00 on August 7, 2026. This represents 1.58% of the company's $2.2B market cap and is a strong vote of confidence from both management and a major shareholder.
Key Financial Metrics
Key Facts
- Total open-market purchases: $34.83M across 7 insiders
- CEO Travis Murdoch bought $1.5M; CFO Rickey James Paul bought $500K
- 10% owner Forbion Growth Opportunities Fund bought $30.24M
- All purchases executed at $18.00/share on August 7, 2026
- Also includes non-cash grants (1M shares) and derivative conversions (132M shares) from Forbion and Jiangsu Hengrui
Financial Impact
$34.83M in insider buying, equal to 1.58% of market cap
Risk Factors
- No specific catalyst disclosed; buying could be tied to a private placement or warrant exercise
- Biotech sector volatility and binary clinical outcomes
- Large derivative conversions by Forbion and Hengrui could signal future selling overhang
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-BRVE-1786370678921 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 10w ago | 3 | $27.66 $26.71 | ▼ −3.43% | ▼ −1.46% | $21.87 (−20.93%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.87 (−16.37%) |
Aug 11, 2026 10w ago | Insider Cluster | $26.15 $27.25 | ▲ +4.21% | ▲ +6.10% | $21.87 (−16.37%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.87 (−20.56%) |
Aug 7, 2026 11w ago | Insider Cluster | $27.53 $29.41 | ▲ +6.83% | ▲ +7.74% | $21.87 (−20.56%) |
Aug 5, 2026 11w ago | Press Release | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
Aug 5, 2026 11w ago | 3 | $29.80 $26.27 | ▼ −11.85% | ▼ −12.45% | $21.87 (−26.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers